This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...